GlassScriptPhysician profile
Chetan A Patel
NPI 1609080894
$20,550.90
in general payments reported to CMS, 2019-2025
40 companies · $3,537 in 2025
The $3,537 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,466 · 2020: $3,195 · 2021: $2,010 · 2022: $3,599 · 2023: $4,203 · 2024: $2,542 · 2025: $3,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,845 · Travel and Lodging: $1,436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,845.16 |
| Travel and Lodging | $1,436.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,669.32 | 2019-2025 | Watchman Flx, Watchman Access System, Avvigo Guidance System |
| Abbott Laboratories | $4,047.21 | 2019-2025 | Dragonfly Opstar, Xience Skypoint, Diamondback Coronary |
| Medical Device Business Services, INC. | $1,504.76 | 2023 | Carto 3 |
| Abiomed | $1,228.76 | 2019-2025 | Impella |
| Siemens Medical Solutions USA, INC. | $989.01 | 2022 | |
| Novartis Pharmaceuticals Corporation | $816.28 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $665.54 | 2019-2023 | Farxiga, Andexxa |
| Inari Medical, INC. | $660.88 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $533.56 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $443.75 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Edwards Lifesciences Corporation | $434.42 | 2023-2025 | Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Medtronic, INC. | $427.73 | 2021-2024 | Onyx Frontier, Symplicity G3, Plasmablade(Tm) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.51 | 2020-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $235.66 | 2019-2025 | Lifevest |
| Pfizer INC. | $234.98 | 2019-2024 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $184.21 | 2022-2025 | Camzyos, Eliquis |
| Biotronik INC. | $152.94 | 2022 | |
| Janssen Pharmaceuticals, INC | $145.82 | 2019-2020 | |
| Biosense Webster, INC. | $144.21 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $121.42 | 2023-2025 | Onpattro |
| Atricure, INC. | $82.41 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $78.26 | 2023-2025 | Verquvo |
| Philips North America LLC | $64.39 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.39 | 2024-2025 | |
| Terumo Medical Corporation | $55.47 | 2025 | Angio-Seal, Metacross Otw, Glidesheath Slender |
| Kiniksa Pharmaceuticals International, Plc | $51.52 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $42.30 | 2019-2020 | |
| Acist Medical Systems, INC. | $35.94 | 2024 | |
| Cardiovascular Systems INC. | $25.24 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $23.37 | 2019 | |
| Penumbra, INC. | $20.82 | 2023 | Indigo System |
| Cordis US Corp. | $19.06 | 2024 | Mynx Control |
| Cardiva Medical, INC. | $18.19 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Impulse Dynamics (USA) INC. | $16.54 | 2024 | Optimizer |
| Chiesi USA, INC. | $13.31 | 2023 | Cleviprex, Kengreal |
| Teleflex LLC | $13.03 | 2020 | |
| Gilead Sciences, INC. | $12.94 | 2019 | |
| Cardinal Health 200 LLC | $11.01 | 2019 | |
| Zoll Medical Corporation | $10.69 | 2022 | |
| Acutus Medical, INC. | $3.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chetan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.